BioHarvest SciencesvsMerck & Company

BHST and MRK stock compared: price, dividend, valuation and results, from SEC filings.

BHST

BioHarvest Sciences Inc.

$1.23

Value $28M

+0.82%
BHST's page

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

BioHarvest Sciences (BHST) has a market value of $28M and Merck & Company (MRK) $341B. Over the last year, with dividends, BHST moved -81.5% and MRK +52.7%. Dividend yield: BHST none, MRK 2.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BHST$28M

    MRK$341B

    MRK is 12,218 times BHST

  • Revenue, 12 months

    BHST$35M

    MRK$67.4B

    MRK is 1,953 times BHST

  • Net income, 12 months

    BHST-$11M

    MRK$2.5B

  • Operating margin

    BHST-16.2%

    MRK–

  • ROIC

    BHST-17.2%

    MRK3.9%

    21.1 points apart

  • P/E

    BHST–

    MRK138.9

  • Dividend yield

    BHST0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    BHST-88.8%

    MRK+94.3%

    183.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BHST-88.8%

MRK+94.3%

010020020222023202420252026
Returns by period
PeriodBHSTWith dividendsMRKWith dividends
1 year since November 17, 2025-81.5%Price -81.5%+52.7%Price +48.4%
3 years since November 17, 2023-71.4%-34.1% a yearPrice -71.4%+48.4%+14.1% a yearPrice +35.4%
5 years since November 17, 2021-88.8%-35.5% a yearPrice -88.8%+94.3%+14.2% a yearPrice +66.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BHSTBioHarvest SciencesMRKMerck & Company

Valuation

BHSTMRK
Valuation
Price$1.23$137.78
Market value$28M$341B
Enterprise value (EV)$6.4M$385B
P/E–138.9
P/E, 5-year median–14.8
P/B1.17.6
EV/EBIT–80.8
Free cash flow yield–4.3%

Results and growth

BHSTMRK
Results and growth
Revenue, 12 months$35M$67.4B
Net income, 12 months-$11M$2.5B
Free cash flow, 12 months-$9.6M$14.7B
Earnings per share, 12 months-$0.60$0.98
Revenue growth, year on year37.0%1.3%
Revenue growth a year, past+65.0%over 2 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

BHSTMRK
Margins and returns on capital
Gross margin59.3%71.8%
Operating margin-16.2%–
Net margin-32.3%3.6%
ROIC-17.2%3.9%
ROE-43.8%5.2%

Balance sheet

BHSTMRK
Balance sheet
Cash$23M$9.7B
Total debt$1.6M$53.8B
Net debt / EBITDA–5.7
Interest cover–2.4×

Dividends and buybacks

BHSTMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.5%
Shareholder yield–4.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BHST or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, BioHarvest Sciences or Merck & Company?

By market value, Merck & Company ($341B) is about 12,218.2 times BioHarvest Sciences ($28M), at today's prices.

How did BHST and MRK stock do over the last 5 years?

Since November 17, 2021, BHST's price moved -88.8% and MRK's +66.8%. With dividends: BHST -88.8% (-35.5% a year), MRK +94.3% (+14.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, BHST or MRK?

The dividend yield at today's price is none for BioHarvest Sciences and 2.47% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, BioHarvest Sciences or Merck & Company?

Over the last twelve months, the net margin was -32.3% for BioHarvest Sciences and 3.6% for Merck & Company, and the operating margin -16.2% and –. Revenue was $35M and $67.4B.

Which is the better investment, BioHarvest Sciences or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.